Moreover, it has been demonstrated that UCP2 is upregulated in response to different pathological states such as insulin resistance, inflammation, oxidative stress, and high levels of FFA, which are all features of MetS [8,11,18]. The gene discussed is UCP2; the disease is metabolic syndrome.